首页 | 本学科首页   官方微博 | 高级检索  
检索        

急性白血病患者实验室证实的黏膜屏障损伤所致血流感染发生机制与研究进展
引用本文:赵慧函,何雨,应燕萍.急性白血病患者实验室证实的黏膜屏障损伤所致血流感染发生机制与研究进展[J].中国感染控制杂志,2024(5):646-651.
作者姓名:赵慧函  何雨  应燕萍
作者单位:1.广西医科大学第一附属医院血液科, 广西 南宁 530021;2.广西医科大学第一附属医院检验科, 广西 南宁 530021;3.广西医科大学第一附属医院护理部, 广西 南宁 530021;4.广西医科大学信息与管理学院, 广西 南宁 530021
基金项目:广西医疗卫生适宜技术开发与推广应用项目(S2023066); 广西医科大学第一附属医院护理临床研究攀登计划项目(YYZS2020031); 广西中青年教师基础能力提升项目(2023KY0128)
摘    要:白血病已成为人类健康的重要威胁,感染并发症是临床白血病顺利治疗的主要障碍。白血病本身肿瘤特点和高强度化学治疗导致肠道屏障完整性损伤,肠道菌群易位是血流感染(BSI)的重要原因。实验室证实的黏膜屏障损伤所致血流感染(MBI-LCBI)是急性白血病患者BSI的重要组成,但相关研究非常有限。本文通过文献分析,综述黏膜屏障损伤、细菌易位,以及MBI-LCBI定义、诊断、流行情况, 分析肠道微生态调节黏膜屏障完整性及MBI-LCBI的作用机制,以期为化学治疗介导黏膜炎及MBI-LCBI的防治及管理提供理论基础。

关 键 词:白血病  血流感染  肠道屏障  细菌易位
收稿时间:2023/2/1 0:00:00

Pathogenesis and research progress of mucosal barrier injury laboratory-confirmed bloodstream infection in patients with acute leukemia
Hui-han ZHAO,Yu HE,Yan-ping YING.Pathogenesis and research progress of mucosal barrier injury laboratory-confirmed bloodstream infection in patients with acute leukemia[J].Chinese Journal of Infection Control,2024(5):646-651.
Authors:Hui-han ZHAO  Yu HE  Yan-ping YING
Institution:1.Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China;2.Department of Laboratory Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China;3.Department of Nursing, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China;4.School of Information and Management, Guangxi Medical University, Nanning 530021, China
Abstract:Leukemia has become an important threat to human health, and infection complications are the main obstacle to the clinical leukemia treatment. The intestinal barrier integrity was damaged due to the tumor characte-ristics of leukemia and high-intensity chemotherapy, intestinal bacterial translocation is an important cause for bloodstream infection. Mucosal barrier injury laboratory-confirmed bloodstream infection (MBI-LCBI) is an important component of bloodstream infection in patients with acute leukemia, but relevant research is very limited. The paper reviews the mucosal barrier injury, bacterial translocation, as well as the definition, diagnosis and prevalence of MBI-LCBI, analyzes the mechanism of intestinal microecology in regulating intestinal mucosal barrier integrity and effect of MBI-LCBI, aiming to provide theoretical basis for prevention, treatment and management of chemotherapy-induced mucositis and MBI-LCBI.
Keywords:leukemia  bloodstream infection  intestinal barrier  bacterial translocation
点击此处可从《中国感染控制杂志》浏览原始摘要信息
点击此处可从《中国感染控制杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号